Multi-Omics Biomarker Clocks
Key Takeaways
- Multi-omics clocks combine measurements from two or more molecular layers, such as DNA methylation, RNA, proteins, and metabolites.
- Integration can capture complementary aspects of ageing, but more input variables do not automatically produce a more valid biological-age measure.
- A clock's meaning depends primarily on its training target: chronological age, mortality, disease burden, or another ageing-related outcome.
- Assay differences, missing data, cohort composition, and limited longitudinal validation remain major barriers to individual interpretation.
Who This Is Useful For
This page is useful for readers comparing molecular ageing clocks or encountering claims that combining several omics layers produces a comprehensive measure of biological age. It explains what is actually integrated, how the resulting score is constructed, and which conclusions the evidence does and does not support. [1] [2]
What Makes a Clock Multi-Omics?
An omics layer is a large set of related biological measurements. Epigenomics records regulatory marks such as DNA methylation; transcriptomics measures RNA abundance; proteomics measures proteins; and metabolomics measures small molecules produced or used by metabolism. A multi-omics clock combines at least two such layers in a model that predicts a defined age-related target. [1] [2]
The term does not describe one standard test. One clock may combine proteins and metabolites to predict chronological age, while another may use methylation-based proxies for protein and metabolite signals to predict a clinical mortality-risk measure. These models have different inputs, targets, and intended interpretations even when both are labelled multi-omics clocks. [3] [4]
Common Designs at a Glance
| Design | How Information Is Combined | Potential Strength | Important Constraint |
|---|---|---|---|
| Early integration | Features from all omics layers enter one model | Can model relationships across molecular layers directly | Large feature counts and scale differences can encourage overfitting |
| Late integration | Separate omics-specific models are combined into an ensemble | Preserves the contribution of each data type | May miss feature-level interactions between layers |
| Latent-factor integration | Shared statistical factors summarize variation across datasets | Reduces dimensionality and can reveal coordinated biology | Factors may be difficult to translate into a simple biological meaning |
| Surrogate-based integration | One scalable assay estimates signals originally observed in other omics | Can reduce the number of assays required at deployment | The final measurement is a proxy for, not a direct assay of, every layer |
These designs solve different practical problems. General multi-omics frameworks demonstrate that integration can be performed through shared latent factors, while ageing-clock studies have used both ensemble models and methylation-based surrogates of other molecular measurements. [3] [4] [5]
Why Combine Molecular Layers?
Different omics layers occupy different positions between inherited sequence, gene regulation, cellular activity, and current physiology. Their age-associated signals overlap only partly, so combining them can represent biological variation that a single layer misses. Reviews of omics clocks and longitudinal multi-omics profiling both support the view that ageing is molecularly heterogeneous rather than one synchronized change. [1] [6]
Integration can also improve prediction in a particular dataset. StackAge, for example, combined plasma proteomic and metabolomic measurements in UK Biobank participants and reported accurate chronological-age estimation together with associations between its derived ageing rate and chronic-disease outcomes. OMICmAge instead integrated proteomic, metabolomic, clinical, and DNA-methylation information around an electronic-medical-record mortality target and was tested in independent cohorts. [3] [4]
The Training Target Defines the Score
A model optimized to predict chronological age learns features that distinguish younger from older participants. A model optimized for mortality or disease learns features associated with that outcome. These objectives can overlap, but they are not interchangeable: biological processes that predict age most accurately need not be the processes that predict mortality most strongly. [1] [7]
The commonly reported "age gap" is the difference, or statistically adjusted difference, between a model estimate and chronological age. It should be interpreted in relation to the model's target and reference population. It is not direct evidence that one universal internal clock is running faster or slower. [1] [8]
Why More Data Can Create More Problems
Multi-omics datasets contain far more candidate features than most ageing cohorts contain participants. Feature selection, regularization, dimensionality reduction, and separation of training from validation data are therefore central to limiting overfitting. Apparent gains can otherwise reflect the development cohort rather than a reproducible ageing signal. [1] [5]
Complete multi-omics profiles are also expensive and uncommon. Participants may be missing one assay, and each platform has its own batch effects, detection limits, and preprocessing choices. Restricting an analysis to people with every measurement can reduce sample size or introduce selection bias, while imputation adds model-dependent uncertainty. [2] [5]
Cross-Sectional Scores and Longitudinal Ageing
Most clocks are trained from cross-sectional samples: many people of different ages are measured once. Such a model can estimate where a profile sits relative to the training cohort, but it does not directly measure the rate at which the same person is changing. Longitudinal multi-omics studies show that individuals can have distinct trajectories and that different molecular systems may change at different rates within one person. [6] [8]
Repeated measurement is therefore important when the research question concerns pace of ageing or responsiveness over time. Even then, short-term physiological variation and assay noise must be separated from persistent change before a shift can be interpreted as altered ageing. [1] [6]
Evidence Quality and Interpretation
Confidence is strong that different omics layers contain partly complementary age-related information and that statistical methods can combine those layers into predictive models. This is supported by general integration methods, longitudinal profiling, and large cohort clock studies. [3] [4] [5] [6]
Confidence is moderate that selected multi-omics clocks add useful disease or mortality information beyond chronological age in populations similar to their validation cohorts. The evidence is model-specific, and newer clocks still require replication across assay platforms, ancestries, health states, and age ranges. [3] [4] [8]
Confidence is weaker for treating a multi-omics score as a comprehensive individual diagnosis of biological age or as a validated surrogate endpoint for lifespan. Combining molecular layers broadens the input, but it does not resolve uncertainty about what biological age is or establish that changing the score changes later health outcomes. [1] [8]
What This Does Not Mean
- It does not mean a model becomes biologically complete because it includes several omics layers. [1]
- It does not mean the features with the largest predictive weights are necessarily causes of ageing. [7]
- It does not mean two multi-omics clocks estimate the same construct when their targets and inputs differ. [3] [4]
- It does not mean strong cohort-level prediction establishes clinical utility for an individual. [8]
Practical Interpretation Examples
- If a multi-omics clock is highly accurate at predicting chronological age: this shows that its inputs contain age-related structure, but does not by itself show that its age gap predicts health or mortality. [1] [7]
- If integration outperforms one omics layer: the gain may reflect complementary information, but it should persist in external data collected with compatible assays. [3] [5]
- If a score changes between two samples: the difference may include biological change, temporary physiological state, and technical variation; repeated validated measurements are needed to distinguish them. [1] [6]
Related Reading
Summary
Multi-omics biomarker clocks combine molecular layers to model an explicitly chosen feature of ageing. They can reveal complementary signals and sometimes improve prediction, but their output remains a statistical estimate shaped by the assays, cohort, integration method, and training target. Their most defensible current use is as research tools whose validity must be demonstrated for each outcome and population, not as universal readings of an individual's biological age. [1] [3] [8]
References
- Rutledge, J., Oh, H. S., & Wyss-Coray, T. (2022). Measuring biological age using omics data. Nature Reviews Genetics. https://www.nature.com/articles/s41576-022-00511-7
- Wu, L., et al. (2022). Integrated multi-omics for novel aging biomarkers and antiaging targets. Biomolecules. https://pmc.ncbi.nlm.nih.gov/articles/PMC8773837/
- Chen, Q., et al. (2026). OMICmAge quantifies biological age by integrating multi-omics with electronic medical records. Nature Aging. https://www.nature.com/articles/s43587-026-01073-7
- Jiang, Y., et al. (2026). StackAge: an ensemble-based clock for precise quantification of biological age using multi-omics data. Briefings in Bioinformatics. https://academic.oup.com/bib/article/27/3/bbag271/8698819
- Argelaguet, R., et al. (2018). Multi-Omics Factor Analysis—a framework for unsupervised integration of multi-omics data sets. Molecular Systems Biology. https://pmc.ncbi.nlm.nih.gov/articles/PMC6010767/
- Ahadi, S., et al. (2020). Personal aging markers and ageotypes revealed by deep longitudinal profiling. Nature Medicine. https://www.nature.com/articles/s41591-019-0719-5
- Ying, K., et al. (2024). High-dimensional Ageome representations of biological aging across functional modules. bioRxiv (preprint). https://pmc.ncbi.nlm.nih.gov/articles/PMC11429788/
- Johnson, A. A., & Shokhirev, M. N. (2024). Contextualizing aging clocks and properly describing biological age. Aging Cell. https://pmc.ncbi.nlm.nih.gov/articles/PMC11634725/
This content is provided for educational purposes only and does not constitute medical advice.